Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on September 10, 2009, regarding events occurring on September 4, 2009. The filing addresses corporate governance changes specifically related to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
Effective September 4, 2009, the Board of Directors filled two vacant seats with the appointment of two new independent directors:
- Mr. Louis J. Lavigne, Jr.: An independent consultant with extensive experience in corporate finance and accounting, including prior roles as CFO and Executive Vice President at Genentech, Inc. He is expected to serve on the Audit Committee.
- Mr. Dennis L. Winger: Former Senior Vice President and CFO of Applied Biosystems, Inc. and Chiron Corporation. He is expected to serve on the Compensation Committee.
Both directors are Class II members and will stand for election at the 2011 annual meeting of stockholders.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No risks or contingencies are disclosed in this specific report. The document confirms there are no related party transactions or special arrangements between the company and the new directors.
Investor Verification Checklist
- Verify the independence status of Mr. Lavigne and Mr. Winger under Nasdaq Stock Market rules.
- Confirm the specific committee assignments (Audit and Compensation) once formally finalized.
- Review the 2008 proxy statement to understand the standard cash and equity compensation package applicable to these new directors.
- Note that these appointments do not impact the current fiscal year's financial results as no financial data is included in this filing.